Article
Efficacy and safety of belimumab in immune thrombocytopenia secondary to systemic lupus erythematosus
2025-09-08
Abstract excerpt
<title>Abstract</title> <p>Objective We aimed to investigate the safety and effectiveness of belimumab for patients with refractory immune thrombocytopenia (ITP) secondary to systemic lupus erythematosus (SLE) Method This is a multi-centre, retrospective cohort study. Data from patients with SLE–ITP received belimumab in addition to basic drug therapy between January 2017 and January 2025 were retrospectively ana...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4576cf72-2835-5d21-85c0-cd48c97f9931
- DOI
- 10.21203/rs.3.rs-7238587/v1
